RenovoRx, Inc. funding
RenovoRx, Inc., a biotechnology company based in Mountain View, CA, filed a Form D with the SEC on April 9, 2026 and reported $10M raised of a $10M offering.
Amount raised$10M
Offering size$10M
Filed with the SECApril 9, 2026
First saleMarch 20, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationMountain View, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far16
Minimum investment$10K
Revenue range$1,000,001 - $5,000,000
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 9
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology